Unknown

Dataset Information

A novel cortical biomarker signature predicts individual pain sensitivity.


ABSTRACT:

Importance

Biomarkers would greatly assist decision making in the diagnosis, prevention and treatment of chronic pain.

Objective

The present study aimed to undertake analytical validation of a sensorimotor cortical biomarker signature for pain consisting of two measures: sensorimotor peak alpha frequency (PAF) and corticomotor excitability (CME).

Design

In this cohort study (recruitment period: November 2020-October 2022), participants experienced a model of prolonged temporomandibular pain with outcomes collected over 30 days. Electroencephalography (EEG) to assess PAF and transcranial magnetic stimulation (TMS) to assess CME were recorded on Days 0, 2 and 5. Pain was assessed twice daily from Days 1-30.

Setting

Data collection occurred at a single centre: Neu

SUBMITTER: Chowdhury NS 

PROVIDER: S-EPMC11469350 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature